Works matching DE "IMMUNOTHERAPY"

Results: 5000

Durable immunotherapeutic response in molecularly complex pulmonary adenosquamous carcinoma: case report and literature review.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1614283

By:

Zhu, Jun;
Xun, Xin;
Liu, Jiayun;
Su, Bin;
Li, Yi;
Chen, Hong;
Huang, Meijin

Publication type:

Article

Senescence-associated signature based on immunotherapy response sequencing reveals PPIL3 as target for bladder cancer treatment and prognosis prediction.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1613056

By:

Du, Kaixuan;
Kang, Ning;
Lin, Yuda;
Jia, Kaipeng;
Shen, Chong;
Wu, Zhouliang;
Hu, Hailong

Publication type:

Article

Does a natural killer need a CAR?

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1606126

By:

Wang, Kangbo;
Zhang, Yumo;
Han, Zhibo;
Wang, Youwei

Publication type:

Article

MACC1 is a potential prognostic biomarker for cancer immunotherapy in lung adenocarcinoma.

Published in:

Carcinogenesis, 2025, v. 46, n. 2, p. 1, doi. 10.1093/carcin/bgaf015

By:

Pan, Changqie;
Zhou, Zhiyuan;
Cao, Jun;
Zhang, Lemeng;
Cheng, Tianli;
Li, Haitao;
Jiang, Zhou;
Huang, Danhui;
Zeng, Dongqiang;
Luo, Yongzhong;
Wu, Jianhua

Publication type:

Article

Triple-negative breast cancer molecular subtypes and potential detection targets for biological therapy indications.

Published in:

Carcinogenesis, 2025, v. 46, n. 2, p. 1, doi. 10.1093/carcin/bgaf006

By:

Zhang, Yanchuan;
Li, Qinghua;
Lan, Jie;
Xie, Guojing;
Zhang, Guangjie;
Cui, Junhao;
Leng, Ping;
Wang, Yingshuang

Publication type:

Article

Establishing a new-onset diabetes-related metabolism signature for predicting the prognosis and immune landscape in pancreatic cancer Open Access.

Published in:

Carcinogenesis, 2025, v. 46, n. 2, p. 1, doi. 10.1093/carcin/bgae072

By:

Yang, Yilei;
Liu, Luyao;
Cui, Haochen;
Cheng, Bin;
Peng, Wang;
Wang, Ronghua;
Wang, Jinlin;
Chen, Wei;
Cao, Mengdie;
Li, Yanling;
Liang, Jingwen;
Chen, Shiru;
Bai, Shuya;
Zhao, Yuchong

Publication type:

Article

Prognostic and Immunotherapeutic Role of TACC3 in Pancancer and Its Impact on Proliferation and Docetaxel Resistance in Lung Adenocarcinoma.

Published in:

Oncology, 2025, v. 103, n. 7, p. 628, doi. 10.1159/000542450

By:

Xu, Jianyu;
Zhu, Ying;
Liu, Qian;
Xu, Chenchang;
Wang, Wenjuan;
Sun, Jiantong;
Ding, Xinyuan;
Liu, Biao;
Chen, Lei

Publication type:

Article

Clinicopathological Characteristics and Perioperative Treatment of Epstein-Barr Virus-Associated Gastric Cancer: A Retrospective Study.

Published in:

Oncology, 2025, v. 103, n. 7, p. 562, doi. 10.1159/000542369

By:

Ji, Zhi;
Zhu, Lila;
Wang, Xia;
Li, Hongli;
Duan, Jingjing;
Zhang, Le;
Deng, Ting;
Liu, Rui;
Ba, Yi

Publication type:

Article

Prognostic Evaluation of Conversion Therapy following Hepatic Arterial Infusion Chemotherapy or Immunotherapy in Patients with Advanced or Transarterial Chemoembolization Unsuitable Intermediate-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study

Published in:

Oncology, 2025, v. 103, n. 7, p. 549, doi. 10.1159/000542291

By:

Kuo, Li-Fu;
Liu, Wen-Chun;
Li, Ming-Feng;
Huang, Fu-Huan;
Chou, Chu-Kuang;
Chen, Tsung-Hsien;
Tsai, Yi-Tseng;
Hsu, Ping-I.;
Li, Chao-Jen;
Wu, I.-Ting;
Tsai, Kun-Feng

Publication type:

Article

The Potential of ESCO2 as a Prognostic and Immunotherapeutic Marker of Pan-Cancer and Its Role in Anti-PD-1 Treatment of Bladder Cancer.

Published in:

Oncology, 2025, v. 103, n. 7, p. 610, doi. 10.1159/000542188

By:

Guo, Wei;
Zhao, Shuo;
Yan, Keqiang;
Fan, Yidong;
Liu, Jikai

Publication type:

Article

Identification of Immune-Related Gene Signature Model for Predicting Lung Cancer Survival and Response to Immunotherapy.

Published in:

Oncology, 2025, v. 103, n. 7, p. 591, doi. 10.1159/000541990

By:

Lin, Wenrong;
Cai, XiaoJun;
Lin, YiJin;
Su, Weikun;
Weng, Guibin;
Chen, Lin;
Ding, Jianming;
Cai, Yibin

Publication type:

Article

Recurrence patterns following neoadjuvant chemotherapy combined with immunotherapy for esophageal squamous cell carcinoma.

Published in:

Diseases of the Esophagus, 2025, v. 38, n. 3, p. 1, doi. 10.1093/dote/doaf034

By:

Wang, Miao;
Wang, Xinyi;
Liu, Zhourong;
Shen, Haixia;
Qi, Baojia;
Fang, Min;
Wang, Jin;
Ji, Yongling;
Zeng, Jian

Publication type:

Article

P.110 A case of refractory NF155 paranodopathy with near complete sponteneous recovery.

Published in:

2025

By:

Mikail, M;
Baker, S

Publication type:

Abstract

P.096 Final pooled analysis of efficacy and safety of rozanolixizumab cycles in patients with generalised myasthenia gravis: MycarinG and open-label extension studies.

Published in:

2025

By:

Bril, V;
Antozzi, C;
Drużdż, A;
Grosskreutz, J;
Habib, AA;
Sacconi, S;
Utsugisawa, K;
Vissing, J;
Vu, T;
Grimson, F;
McDonough, B;
Pulido-Valdeolivas, I;
Tarancón, T

Publication type:

Abstract

P.093 A case of refractory NF155 Paranodal CIDP with near-complete spontaneous recovery.

Published in:

2025

By:

Mikail, M;
Baker, SK

Publication type:

Abstract

P.033 Long-term efficacy of Efgartigimod PH20 SC in patients with chronic inflammatory demyelinating polyneuropathy: interim results from the ADHERE+ study.

Published in:

2025

By:

Allen, JA;
Lin, J;
Stettner, M;
Guptill, J;
Gwathmey, K;
Istas, G;
De Roeck, A;
Kuwabara, S;
Lauria, G;
Querol, L;
Suresh, N;
Karam, C;
Skripuletz, T;
Rinaldi, S;
Echaniz-Laguna, A;
Van Hoorick, B;
Yamasaki, R;
Katzberg, H;
Van Doorn, PA;
Lewis, RA

Publication type:

Abstract

D.6 Changes in intravenous or subcutaneous immunoglobulin usage before and after efgartigimod initiation in patients with Myasthenia Gravis.

Published in:

2025

By:

Kassardjian, C;
Qi, C;
Narayanaswami, P;
Smith, A;
Mahajerin, A;
Campbell, R;
Jefferson, M;
Menon, R;
Selvaraj, S;
Sato, M;
Wolfe, G

Publication type:

Abstract

Comparative Survival Analysis of Anti‐Angiogenic Agent Plus Immunochemotherapy in NSCLC Patients After Frontline EGFR‐TKI Treatment: A Retrospective Cohort Study.

Published in:

Kaohsiung Journal of Medical Sciences, 2025, v. 41, n. 7, p. 1, doi. 10.1002/kjm2.70023

By:

Su, Yi‐Tse;
Tey, Shu‐Farn;
Lee, Chung‐Ta;
Lin, Chien‐Yu;
Tsai, Jeng‐Shiuan;
Lin, Chien‐Chung;
Kuo, Chin‐Wei

Publication type:

Article

Changes in scanographic bone mineral density in melanoma patients treated with immunotherapy: a new irAE from real-life data.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-08974-4

By:

Baddi, Soukayna;
Suarez, Dimitri;
Ruet, Alexis;
Van Butsel, Théo;
Cerasuolo, Damiano;
Rat, Anne-Christine;
L'Orphelin, Jean-Matthieu

Publication type:

Article

Boosting cancer immunotherapy: drug delivery systems leveraging ferroptosis and immune checkpoint blockade.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1611299

By:

Zhang, Ting;
Gu, Fanlin;
Lin, Wei;
Shao, Haiyan;
Jiang, Aiguo;
Guan, Xingang

Publication type:

Article

Abscopal Effects and Immunomodulation in Skin Cancer Therapy.

Published in:

American Journal of Clinical Dermatology, 2025, v. 26, n. 4, p. 555, doi. 10.1007/s40257-025-00943-x

By:

Nahm, William J.;
Sakunchotpanit, Goranit;
Nambudiri, Vinod E.

Publication type:

Article

Combination therapy with levofloxacin and the probiotic Clostridium butyricumMIYAIRI 588 enhances immune checkpoint inhibitor efficacy.

Published in:

International Journal of Cancer, 2025, v. 157, n. 5, p. 993, doi. 10.1002/ijc.35472

By:

Tajima, Kohei;
Hosonuma, Masahiro;
Funayama, Eiji;
Isobe, Junya;
Baba, Yuta;
Murayama, Masakazu;
Narikawa, Yoichiro;
Toyoda, Hitoshi;
Tsurui, Toshiaki;
Maruyama, Yuki;
Sasaki, Aya;
Amari, Yasunobu;
Yamazaki, Yoshitaka;
Nakashima, Rie;
Shida, Midori;
Sasaki, Akiko;
Sambe, Takehiko;
Wada, Satoshi;
Tsuji, Mayumi;
Kiuchi, Yuji

Publication type:

Article

Prognostic impact of the timing of immunotherapy in first‐line immunochemotherapy for patients with advanced lung adenocarcinoma: A propensity score‐matched analysis.

Published in:

International Journal of Cancer, 2025, v. 157, n. 5, p. 916, doi. 10.1002/ijc.35447

By:

Sun, Yanxin;
Deng, Zhenzhen;
Sun, Haifeng;
Wei, Xiaojuan;
Wang, Leirong;
Wang, Shuyun;
Gao, Aiqin;
Sun, Yuping;
Li, Juan

Publication type:

Article

Tumor-associated macrophages: role in tumorigenesis and immunotherapy implications.

Published in:

Journal of Cancer, 2021, v. 12, n. 1, p. 54, doi. 10.7150/jca.49692

By:

Shunyao Zhu;
Ziyi Luo;
Xixi Li;
Xi Han;
Senlin Shi;
Ting Zhang

Publication type:

Article

A new era in myeloma: the advent of chimeric antigen receptor‐T (CAR‐T) cells and bispecific antibodies.

Published in:

Internal Medicine Journal, 2025, v. 55, n. 5, p. 714, doi. 10.1111/imj.16647

By:

Ho, P. Joy;
Li, Eric W.

Publication type:

Article

췌장암의 항암치료: 최신 지견과 향후 전략.

Published in:

Journal of the Korean Medical Association / Taehan Uisa Hyophoe Chi, 2025, v. 68, n. 6, p. 383, doi. 10.5124/jkma.25.0061

By:

Chon, Hong Jae

Publication type:

Article

Benign tumors broaden the field of application for immunotherapy.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1593960

By:

Youssef, Mohamed A.;
Al-Sharif, Hisham;
McGrath, Brian T.;
Picken, Maria M.;
Le Poole, I. Caroline

Publication type:

Article

Characterization of the clinical relevance and hypoallergenic peptides of the newly evidenced major allergen Hum j 1.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1588870

By:

Cheng, Ya-Li;
Li, Qiong;
Yang, Yong-Shi;
Hou, Yi-Bo;
Xu, Zhi-Qiang;
Wei, Ji-Fu;
Sun, Jin-Lyu

Publication type:

Article

Inequalities in Access to Specialist Allergy Services in the United Kingdom: A Report From the BSACI Registry for Immunotherapy (BRIT).

Published in:

Clinical & Experimental Allergy, 2025, v. 55, n. 6, p. 458, doi. 10.1111/cea.70034

By:

Erlewyn‐Lajeunesse, Mich;
Villa, Luciano Perfetti;
Shaikh, Shifa;
Smith, Maria;
Balodima, Vasiliki;
Baker, Sarah;
Dawson, Tom;
Ewan, Pamela;
Khan, Sujoy;
Marriage, Deborah;
Michaelis, Louise;
Ozygit, Leyla Pur;
Thursby‐Pelham, Anna;
Warner, Amena;
Maslovskaya, Olga;
Alachkar, Hana;
Berkovitz, Saul;
Bhole, Malini;
Billahallli, Thippeswamy;
Brough, Helen A

Publication type:

Article

Efficacy and Safety of Ofatumumab Treatment for Anti‐NMDA Receptor Autoimmune Encephalitis (OFF‐AE): A Prospective, Multicenter Cohort Study.

Published in:

Annals of Neurology, 2025, v. 98, n. 1, p. 80, doi. 10.1002/ana.27218

By:

Guo, Kundian;
Peng, Fuhua;
Liu, Jia;
Long, Youming;
Guo, Shougang;
Wang, Honghao;
Yu, Gang;
Zhang, Yanlin;
Han, Xiong;
Tu, Ewen;
Zheng, Yake;
Huang, Jialu;
Zhou, Yanxia;
An, Dongmei;
Lin, Guanyan;
Wang, Baojie;
Wang, Yuanyuan;
Yang, Ping;
Jiang, Yu;
Cui, Beijia

Publication type:

Article

The Evolution of Multidisciplinary Head and Neck Cancer Treatment.

Published in:

Laryngoscope, 2025, v. 135, n. 7, p. 2255, doi. 10.1002/lary.32064

By:

Contrera, Kevin J.;
Reddy, Pooja D.;
Helou, Vanessa;
Myers, Jeffrey N.;
Skinner, Heath D.;
Ferrarotto, Renata;
Myers, Eugene N.

Publication type:

Article

Advancing understanding of autoimmune diseases and lung cancer: trends, themes, and future directions.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-03145-3

By:

Rao, Hao-Han;
Xie, Wan-Chen;
Guo, Feng;
Chen, Huan-Wen

Publication type:

Article

Knowledge mapping of micro/nanomotors in cancer treatment: a bibliometric analysis (2006–2025).

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-03087-w

By:

Song, Ying;
Zhao, Kai;
Yang, Yan;
Yu, Haiming

Publication type:

Article

mRNA vaccines and SiRNAs targeting cancer immunotherapy: challenges and opportunities.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-03070-5

By:

Lv, Zhen;
Dai, Yuheng

Publication type:

Article

A phase II single-arm study of combination pembrolizumab and olaparib in the treatment of patients with advanced biliary tract cancer.

Published in:

NPJ Precision Oncology, 2025, v. 9, n. 1, p. 1, doi. 10.1038/s41698-025-01009-1

By:

Sadagopan, Narayanan;
Wang, Hongkun;
Yin, Chao;
Weinberg, Benjamin Adam;
Noel, Marcus Smith;
Mukherji, Reetu;
Geng, Xue;
Marshall, John Lindsay;
He, Aiwu Ruth

Publication type:

Article

Efficacy of dostarlimab in recurrent or advanced mismatch Repair-Deficient endometrial Cancer as a Single-Agent therapy: A systematic review and Meta-Analysis.

Published in:

DARU: Journal of Pharmaceutical Sciences, 2025, v. 33, n. 2, p. 1, doi. 10.1007/s40199-025-00564-z

By:

Rezaei, Ramazan;
Khani, Hedieh Haji Khodaverdi

Publication type:

Article

Intratumoral expression of IL-12 and CD40 ligand (CD154) from plasmids generates antitumor responses that eliminate tumoral T regs.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-09535-5

By:

Ho, Gregory W.;
Santos, Alicia;
Fields, Jennifer;
Rosato, Pamela C.;
Turk, Mary Jo;
Steinmetz, Nicole F.;
Fiering, Steven

Publication type:

Article

Metabolic alterations driven by LDHA in CD8 + T cells promote immune evasion and therapy resistance in NSCLC.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-87361-5

By:

Wen, Hao;
Zhang, Panpan;
Zhao, Juan;
Liu, Yakui;
Wan, Lei;
Li, Haoran;
Yi, Jun;
Li, Xinqiang

Publication type:

Article

Immune cells mediate the association between the plasma lipidome and pancreatic cancer: a Mendelian randomization analysis.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-05898-x

By:

Ma, Chunhong;
Liu, Dandan;
Ye, Changchun;
Chen, Zilu;
Kong, Ranran;
Li, Jianzhong;
Sun, Xuejun;
Xu, Zhengshui

Publication type:

Article

Tocilizumab as a targeted immunomodulatory therapy in the management of severe respiratory illnesses: a multicenter cohort study of COVID-19 patients.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-08638-3

By:

Al Mutair, Abbas;
Alhumaid, Saad;
Ahmad, Gasmelseed Y.;
Rabaan, Ali A.;
Alkubati, Sameer A.;
Albaqawi, Hamdan;
Alrasheeday, Awatif M.;
Alshammari, Bushra;
Alsaleh, Kawther;
Mottershead, Richard;
Daniyal, Muhammad;
Al-Omari, Awad

Publication type:

Article

NR4A3 potentials M1-like macrophage polarization to facilitate anti-tumor immune responses in breast cancer.

Published in:

NPJ Breast Cancer, 2025, v. 11, n. 1, p. 1, doi. 10.1038/s41523-025-00785-0

By:

Qian, Yi-yu;
Jin, Ning;
Rao, Shan-shan;
Wang, Ya;
Li, Xin;
Pan, Wen;
Huang, Pu;
Wang, Si-yuan;
Li, Ping-fei;
Lv, Yan-kai;
Gao, Qing-lei;
Xia, Yu

Publication type:

Article

Computation strategies and clinical applications in neoantigen discovery towards precision cancer immunotherapy.

Published in:

Biomarker Research, 2025, v. 13, n. 1, p. 1, doi. 10.1186/s40364-025-00808-9

By:

Wang, Zhenchang;
Gu, Yu;
Sun, Xiao;
Huang, Hao

Publication type:

Article

Endoplasmic Reticulum‐Targeted Photodynamic Therapy Combined with Autophagy Inhibition to Enhance Synergistic Immunotherapy for Triple‐Negative Breast Cancer.

Published in:

Chemistry - A European Journal, 2025, v. 31, n. 34, p. 1, doi. 10.1002/chem.202500146

By:

Yuan, Gankun;
Yang, Ruyue;
Wen, Wenjing;
Wei, Zhaoyi;
Song, Meiru;
Zhang, Lingyang;
Hou, Kun;
Liang, Gaofeng

Publication type:

Article

The current and future role of systemic therapy in non–muscle‐invasive bladder cancer.

Published in:

Cancer (0008543X), 2025, v. 131, n. 13, p. 1, doi. 10.1002/cncr.35966

By:

Lazarovich, Alon;
Sweis, Randy F.

Publication type:

Article

Top advances of the year: Sarcoma.

Published in:

Cancer (0008543X), 2025, v. 131, n. 13, p. 1, doi. 10.1002/cncr.35965

By:

Vierra, Mason;
Brett, Jamie;
Wang, Jiping

Publication type:

Article

First‐in‐human phase 1 study of KHK2455 monotherapy and in combination with mogamulizumab in patients with advanced solid tumors.

Published in:

Cancer (0008543X), 2025, v. 131, n. 13, p. 1, doi. 10.1002/cncr.35939

By:

Yap, Timothy A.;
Rixe, Olivier;
Baldini, Capucine;
Brown‐Glaberman, Ursa;
Efuni, Sergey;
Hong, David S.;
Massard, Christophe;
Muzaffar, Jameel;
Varga, Andreea;
Yilmaz, Emrullah;
Ikawa, Yuta;
Shiue, Lisa H.;
Liu, Yi;
Hruska, Matthew W.;
Zhao, Henry;
Tokunaga, Akihiro;
Sahebjam, Solmaz

Publication type:

Article

FDA approves durvalumab for perioperative immunotherapy for patients with muscle‐invasive bladder cancer: In a prespecified analysis, the trial demonstrated a statistically significant improvement in event‐free survival and overall survival.

Published in:

Cancer (0008543X), 2025, v. 131, n. 13, p. 1, doi. 10.1002/cncr.35912

By:

Nierengarten, Mary Beth

Publication type:

Article

Clinical Outcomes of Perioperative Immunotherapy in Resectable Non–Small Cell Lung Cancer.

Published in:

JAMA Network Open, 2025, v. 8, n. 6, p. e2517953, doi. 10.1001/jamanetworkopen.2025.17953

By:

Desai, Aakash;
Schwed, Karen;
Kalesinskas, Laurynas;
Yuan, Qianyu;
Bryan, Jonathan;
Keane, Catherine;
Fidyk, Erin;
Castellanos, Emily;
Cohen, Aaron B.;
Harrison, Katherine;
Ho, George;
Marinescu, Anca;
Leal, Ticiana A.

Publication type:

Article

Immunotherapy for Resectable Non–Small Cell Lung Cancer—Not If, But When.

Published in:

2025

By:

Reed-Guy, Lauren;
Marmarelis, Melina E.

Publication type:

Opinion

Treatments for postorgasmic illness syndrome: a systematic review Open Access.

Published in:

Journal of Sexual Medicine, 2025, v. 22, n. 7, p. 1236, doi. 10.1093/jsxmed/qdaf112

By:

Ponce, Sarah;
Chapalamadugu, Meghana;
Levine, Samantha;
Stokes, Cameron;
Radillo, Karla;
Johnson, Olivia;
Bronson, Isaac;
Rubin, Rachel S

Publication type:

Article